174 related articles for article (PubMed ID: 8186356)
1. Strategies for inhibiting the effects of thrombin.
Harker LA
Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S47-58; discussion S59-64. PubMed ID: 8186356
[TBL] [Abstract][Full Text] [Related]
2. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.
Kelly AB; Maraganore JM; Bourdon P; Hanson SR; Harker LA
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6040-4. PubMed ID: 1385867
[TBL] [Abstract][Full Text] [Related]
4. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
Hortin GL; Trimpe BL
J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II.
Hortin GL; Tollefsen DM; Benutto BM
J Biol Chem; 1989 Aug; 264(24):13979-82. PubMed ID: 2760054
[TBL] [Abstract][Full Text] [Related]
6. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.
Bates SM; Weitz JI
Am J Cardiol; 1998 Oct; 82(8B):12P-18P. PubMed ID: 9809887
[TBL] [Abstract][Full Text] [Related]
7. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thrombin's clotting activity by synthetic peptide segments of its inhibitors and substrates.
Hortin GL; Benutto BM
Biochem Biophys Res Commun; 1990 Jun; 169(2):437-42. PubMed ID: 2357214
[TBL] [Abstract][Full Text] [Related]
9. [Thrombin and its pharmacologic regulation].
Guillin MC
Presse Med; 1998 Jun; 27 Suppl 2():22-7. PubMed ID: 9765662
[TBL] [Abstract][Full Text] [Related]
10. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
[TBL] [Abstract][Full Text] [Related]
11. Direct thrombin inhibitors.
Maffrand JP
Nouv Rev Fr Hematol (1978); 1992; 34(6):405-19. PubMed ID: 1300540
[TBL] [Abstract][Full Text] [Related]
12. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J
Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336
[TBL] [Abstract][Full Text] [Related]
13. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
[TBL] [Abstract][Full Text] [Related]
14. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
15. Chimeric antithrombin peptide. Characterization of an Arg-Gly-Asp (RGD)- and hirudin carboxyl terminus-containing synthetic peptides.
Church FC; Phillips JE; Woods JL
J Biol Chem; 1991 Jun; 266(18):11975-9. PubMed ID: 2050691
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis.
Biemond BJ; Friederich PW; Levi M; Vlasuk GP; Büller HR; ten Cate JW
Circulation; 1996 Jan; 93(1):153-60. PubMed ID: 8616922
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of endothelial cell-mediated generation of activated protein C by direct and antithrombin-dependent thrombin inhibitors.
Linder R; Frebelius S; Jansson K; Swedenborg J
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):139-46. PubMed ID: 12632023
[TBL] [Abstract][Full Text] [Related]
19. Thrombin inhibition by hirudin: how hirudin inhibits thrombin.
Fenton JW; Villanueva GB; Ofosu FA; Maraganore JM
Haemostasis; 1991; 21 Suppl 1():27-31. PubMed ID: 1894193
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hirudin and hirudin PA C-terminal fragments and related analogs as antithrombin agents.
Krstenansky JL; Owen TJ; Yates MT; Mao SJ
Thromb Res; 1988 Oct; 52(2):137-41. PubMed ID: 3194888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
